{"disease":{"id":"neurofibromatosis-type-2","name":"neurofibromatosis type 2"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01552434","title":"Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":155,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04374305","title":"Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Scott R. Plotkin, MD, PhD","has_results":false},{"nct_id":"NCT03210285","title":"WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"University Hospital Tuebingen","has_results":false},{"nct_id":"NCT01125046","title":"Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Northwestern University","has_results":true},{"nct_id":"NCT05130866","title":"Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"Recursion Pharmaceuticals Inc.","has_results":false},{"nct_id":"NCT01767792","title":"Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":true},{"nct_id":"NCT02246231","title":"Effect of Implant Position on Magnetic Resonance Image Distortion","phase":"NA","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Manchester University NHS Foundation Trust","has_results":false},{"nct_id":"NCT01345136","title":"Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT02589912","title":"Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Massachusetts Eye and Ear Infirmary","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}